{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:27:46Z","timestamp":1785338866619,"version":"3.55.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>HLA-DRB1 is a sarcoidosis risk gene, and the *03:01 allele is strongly associated with disease resolution in European sarcoidosis cases. Whereas the HLA-DRB1 variation is associated with sarcoidosis susceptibility in African Americans, DRB1 risk alleles are not as well defined, and associations with disease resolution have not been studied. Associations between genotyped and imputed HLA-DRB1 alleles and disease susceptibility\/resolution were evaluated in a sample of 1,277 African-American patients with sarcoidosis and 1,467 control subjects. In silico binding assays were performed to assess the functional significance of the associated alleles. Increased disease susceptibility was associated with the HLA-DRB1 alleles *12:01 (odds ratio [OR], 2.11; 95% confidence interval [CI], 1.65\u20132.69; P\u2009=\u20093.2\u2009\u00d7\u200910\u22129) and *11:01 (OR, 1.69; 95% CI, 1.42\u20132.01; P\u2009=\u20093.0\u2009\u00d7\u200910\u22129). The strongest protective association was found with *03:01 (OR, 0.56; 95% CI, 0.44\u20130.73; P\u2009=\u20091.0\u2009\u00d7\u200910\u22125). The African-derived allele *03:02 was associated with decreased risk of persistent radiographic disease (OR, 0.52; 95% CI, 0.37\u20130.72; P\u2009=\u20091.3\u2009\u00d7\u200910\u22124), a finding consistent across the three component studies comprising the analytic sample. The DRB1*03:01 association with disease persistence was dependent upon local ancestry, with carriers of at least one European allele at DRB1 at a decreased risk of persistent disease (OR, 0.36; 95% CI, 0.14\u20130.94; P\u2009=\u20090.037). Results of in silico binding analyses showed that DRB1*03:01 consistently demonstrated the highest binding affinities for six bacterial peptides previously found in sarcoidosis granulomas, whereas *12:01 displayed the lowest binding affinities. This study has identified DRB1*03:01 and *03:02 as novel alleles associated with disease susceptibility and course in African Americans. Further investigation of DRB1*03 alleles may uncover immunologic factors that favor sarcoidosis protection and resolution among African Americans.<\/jats:p>","DOI":"10.1165\/rcmb.2014-0227oc","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T16:48:33Z","timestamp":1418662113000},"page":"206-216","source":"Crossref","is-referenced-by-count":57,"title":["Association of\n                    <i>HLA<\/i>\n                    -\n                    <i>DRB1<\/i>\n                    with Sarcoidosis Susceptibility and Progression in African Americans"],"prefix":"10.1093","volume":"53","author":[{"given":"Albert M.","family":"Levin","sequence":"first","affiliation":[{"name":"Department of Public Health Sciences and"},{"name":"Center for Bioinformatics, Henry Ford Health System, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indra","family":"Adrianto","sequence":"additional","affiliation":[{"name":"Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrani","family":"Datta","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences and"},{"name":"Center for Bioinformatics, Henry Ford Health System, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Iannuzzi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Upstate Medical University, Syracuse, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri","family":"Trudeau","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences and"},{"name":"Center for Bioinformatics, Henry Ford Health System, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonder P.","family":"Drake","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney G.","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Rybicki","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,8,1]]},"reference":[{"key":"2026021122332494900_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2007-970330","article-title":"Genetics of sarcoidosis","volume":"28","author":"Iannuzzi","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"2026021122332494900_bib2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4049\/jimmunol.1201891","article-title":"HLA class II molecules influence susceptibility versus protection in inflammatory diseases by determining the cytokine profile","volume":"190","author":"Mangalam","year":"2013","journal-title":"J Immunol"},{"key":"2026021122332494900_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humimm.2011.10.016","article-title":"HLA-DRB1 allele frequencies and C4 copy number variation in Finnish sarcoidosis patients and associations with disease prognosis","volume":"73","author":"Wennerstr\u00f6m","year":"2012","journal-title":"Hum Immunol"},{"key":"2026021122332494900_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.humimm.2011.03.020","article-title":"Human leukocyte antigen-A, -B, and -DRB1 alleles and sarcoidosis in Chinese Han subjects","volume":"72","author":"Zhou","year":"2011","journal-title":"Hum Immunol"},{"key":"2026021122332494900_bib5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1183\/09031936.00025011","article-title":"HLA-DRB1* alleles and symptoms associated with Heerfordt\u2019s syndrome in sarcoidosis","volume":"38","author":"Darlington","year":"2011","journal-title":"Eur Respir J"},{"key":"2026021122332494900_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1465-9921-11-25","article-title":"Different hla-drb1 allele distributions in distinct clinical subgroups of sarcoidosis patients","volume":"11","author":"Grunewald","year":"2010","journal-title":"Respir Res"},{"key":"2026021122332494900_bib7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1086\/378097","article-title":"HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites","volume":"73","author":"Rossman","year":"2003","journal-title":"Am J Hum Genet"},{"key":"2026021122332494900_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1165\/rcmb.2003-0007OC","article-title":"Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians","volume":"29","author":"Sharma","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021122332494900_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1399-0039.2001.057001087.x","article-title":"HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis","volume":"57","author":"Bogunia-Kubik","year":"2001","journal-title":"Tissue Antigens"},{"key":"2026021122332494900_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1165\/ajrcmb.25.3.4261","article-title":"Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis","volume":"25","author":"Foley","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021122332494900_bib11","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/hmg\/ddq325","article-title":"Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups","volume":"19","author":"Sato","year":"2010","journal-title":"Hum Mol Genet"},{"key":"2026021122332494900_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"key":"2026021122332494900_bib13","first-page":"204","article-title":"Two year prognosis of sarcoidosis: the ACCESS experience","volume":"20","author":"Judson","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021122332494900_bib14","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021122332494900_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-0039.2005.00370.x","article-title":"Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with L\u00f6fgren\u2019s syndrome in Czech patients with sarcoidosis","volume":"65","author":"Mrazek","year":"2005","journal-title":"Tissue Antigens"},{"key":"2026021122332494900_bib16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.humimm.2005.04.003","article-title":"Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602-DRB1*150101","volume":"66","author":"Voorter","year":"2005","journal-title":"Hum Immunol"},{"key":"2026021122332494900_bib17","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1164\/rccm.200303-459OC","article-title":"Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients","volume":"169","author":"Grunewald","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021122332494900_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1568-9972(01)00004-0","article-title":"Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions","volume":"1","author":"Candore","year":"2002","journal-title":"Autoimmun Rev"},{"key":"2026021122332494900_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.0954-6820.1953.tb07039.x","article-title":"Primary pulmonary sarcoidosis: I. Early signs and symptoms","volume":"145","author":"L\u00f6fgren","year":"1953","journal-title":"Acta Med Scand"},{"key":"2026021122332494900_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.200807-1082OC","article-title":"L\u00f6fgren\u2019s syndrome: human leukocyte antigen strongly influences the disease course","volume":"179","author":"Grunewald","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021122332494900_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/368215a0","article-title":"Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide","volume":"368","author":"Stern","year":"1994","journal-title":"Nature"},{"key":"2026021122332494900_bib22","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0969-2126(97)00288-8","article-title":"The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding","volume":"5","author":"Murthy","year":"1997","journal-title":"Structure"},{"key":"2026021122332494900_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10875-009-9311-y","article-title":"Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101","volume":"30","author":"Oswald-Richter","year":"2010","journal-title":"J Clin Immunol"},{"key":"2026021122332494900_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/1471-2105-11-568","article-title":"Peptide binding predictions for HLA DR, DP and DQ molecules","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"2026021122332494900_bib25","first-page":"100","article-title":"M. avium binding to HLA-DR expressed alleles in silico: a model of phenotypic susceptibility to sarcoidosis","volume":"25","author":"Saltini","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021122332494900_bib26","doi-asserted-by":"crossref","first-page":"e43907","DOI":"10.1371\/journal.pone.0043907","article-title":"Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility","volume":"7","author":"Adrianto","year":"2012","journal-title":"PLoS One"},{"key":"2026021122332494900_bib27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/tpj.2013.18","article-title":"HIBAG\u2014HLA genotype imputation with attribute bagging","volume":"14","author":"Zheng","year":"2014","journal-title":"Pharmacogenomics J"},{"key":"2026021122332494900_bib28","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0895-4356(99)00142-0","article-title":"Design of a case control etiologic study of sarcoidosis (ACCESS)","volume":"52","author":"Group","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"2026021122332494900_bib29","first-page":"115","article-title":"A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study","volume":"22","author":"Rybicki","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021122332494900_bib30","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1164\/rccm.200209-1097OC","article-title":"Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans","volume":"167","author":"Iannuzzi","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021122332494900_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/gene.2010.56","article-title":"A genome-wide admixture scan for ancestry-linked genes predisposing to sarcoidosis in African-Americans","volume":"12","author":"Rybicki","year":"2011","journal-title":"Genes Immun"},{"key":"2026021122332494900_bib32","first-page":"75","article-title":"Defining organ involvement in sarcoidosis: the access proposed instrument. Access Research Group. A case control etiologic study of sarcoidosis","volume":"16","author":"Judson","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021122332494900_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2156-15-72","article-title":"Performance of HLA allele prediction methods in African Americans for class II genes HLA-DRB1, -DQB1, and -DPB1","volume":"15","author":"Levin","year":"2014","journal-title":"BMC Genet"},{"key":"2026021122332494900_bib34","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/gepi.21811","article-title":"Efficient generalized least squares method for mixed population and family-based samples in genome-wide association studies","volume":"38","author":"Li","year":"2014","journal-title":"Genet Epidemiol"},{"key":"2026021122332494900_bib35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ng.548","article-title":"Variance component model to account for sample structure in genome-wide association studies","volume":"42","author":"Kang","year":"2010","journal-title":"Nat Genet"},{"key":"2026021122332494900_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ajhg.2007.09.022","article-title":"Estimating local ancestry in admixed populations","volume":"82","author":"Sankararaman","year":"2008","journal-title":"Am J Hum Genet"},{"key":"2026021122332494900_bib37","doi-asserted-by":"crossref","first-page":"e92646","DOI":"10.1371\/journal.pone.0092646","article-title":"Admixture fine-mapping in African Americans implicates XAF1 as a possible sarcoidosis risk gene","volume":"9","author":"Levin","year":"2014","journal-title":"PLoS One"},{"key":"2026021122332494900_bib38","doi-asserted-by":"crossref","first-page":"D854","DOI":"10.1093\/nar\/gkp1004","article-title":"The immune epitope database 2.0","volume":"38","author":"Vita","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"2026021122332494900_bib39","doi-asserted-by":"crossref","first-page":"e1000048","DOI":"10.1371\/journal.pcbi.1000048","article-title":"A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach","volume":"4","author":"Wang","year":"2008","journal-title":"PLoS Comput Biol"},{"key":"2026021122332494900_bib40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2105-10-296","article-title":"NN-align: an artificial neural network-based alignment algorithm for MHC class II peptide binding prediction","volume":"10","author":"Nielsen","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"2026021122332494900_bib41","doi-asserted-by":"crossref","first-page":"e1000107","DOI":"10.1371\/journal.pcbi.1000107","article-title":"Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan","volume":"4","author":"Nielsen","year":"2008","journal-title":"PLoS Comput Biol"},{"key":"2026021122332494900_bib42","first-page":"66","article-title":"Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments","volume":"22","author":"Grosser","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021122332494900_bib43","first-page":"18","article-title":"The investigation of HLA microsatellites influence in predisposition to sarcoidosis among Croatians","volume":"28","author":"Grubi\u0107","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021122332494900_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1399-0039.2007.00842.x","article-title":"HLA class II amino acid epitopes as susceptibility markers of sarcoidosis","volume":"70","author":"Voorter","year":"2007","journal-title":"Tissue Antigens"},{"key":"2026021122332494900_bib45","doi-asserted-by":"crossref","first-page":"685, author reply 685","DOI":"10.1164\/ajrccm.180.7.685","article-title":"Reactivity to mycobacterial antigens by patients with L\u00f6fgren\u2019s syndrome as a model of phenotypic susceptibility to disease and disease progression","volume":"180","author":"Amicosante","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021122332494900_bib46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0198-8859(96)00061-4","article-title":"The impact of DR3 microvariation on peptide binding: the combinations of specific DR beta residues critical to binding differ for different peptides","volume":"49","author":"Posch","year":"1996","journal-title":"Hum Immunol"},{"key":"2026021122332494900_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0198-8859(94)00074-Z","article-title":"Microvariation creates significant functional differences in the DR3 molecules","volume":"42","author":"Posch","year":"1995","journal-title":"Hum Immunol"},{"key":"2026021122332494900_bib48","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/dme.12148","article-title":"HLA class II gene associations in African American type 1 diabetes reveal a protective HLA-DRB1*03 haplotype","volume":"30","author":"Howson","year":"2013","journal-title":"Diabet Meds"},{"key":"2026021122332494900_bib49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrrheum.2010.176","article-title":"Genetic susceptibility to systemic lupus erythematosus in the genomic era","volume":"6","author":"Deng","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"2026021122332494900_bib50","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/1529-0131(199807)41:7<1161::AID-ART4>3.0.CO;2-K","article-title":"Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture","volume":"41","author":"Reveille","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2026021122332494900_bib51","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2012.03.045","article-title":"Genome-wide ancestry association testing identifies a common European variant on 6q14.1 as a risk factor for asthma in African American subjects","volume":"130","author":"Torgerson","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"2026021122332494900_bib52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ng.1076","article-title":"Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis","volume":"44","author":"Raychaudhuri","year":"2012","journal-title":"Nat Genet"},{"key":"2026021122332494900_bib53","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"Baughman","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021122332494900_bib54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00063198-199909000-00005","article-title":"Clinical courses and prognoses of pulmonary sarcoidosis","volume":"5","author":"Nagai","year":"1999","journal-title":"Curr Opin Pulm Med"},{"key":"2026021122332494900_bib55","first-page":"167","article-title":"Sarcoidosis: a long-term follow up study","volume":"17","author":"Chappell","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021122332494900_bib56","first-page":"29","article-title":"Sarcoidosis: epidemiology and prognosis. A 15-year European study","volume":"130","author":"Hillerdal","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"2026021122332494900_bib57","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026021122332494900_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1586\/eci.11.76","article-title":"HLA associations and L\u00f6fgren\u2019s syndrome","volume":"8","author":"Grunewald","year":"2012","journal-title":"Expert Rev Clin Immunol"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/53\/2\/206\/66832526\/ajrcmb_53_2_206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/53\/2\/206\/66832526\/ajrcmb_53_2_206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T03:35:12Z","timestamp":1770867312000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/53\/2\/206\/8467862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,1]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,8,1]]},"published-print":{"date-parts":[[2015,8,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2014-0227oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,8]]},"published":{"date-parts":[[2015,8,1]]}}}